GST Refund for Pharmaceutical Manufacturers ITC Refund India
India’s pharmaceutical industry is worth $130 billion. But behind those numbers, most pharma manufacturers are quietly losing lakhs every year blocked input tax credit sitting idle in their GST ledger, never recovered, never even noticed.
After the GST 2.0 reforms of September 2025, the problem has only gotten bigger. APIs and raw materials are still taxed at 18%. Finished medicines are now taxed at 5% or completely Nil. The gap between what you pay on inputs and what you collect on outputs is widening. That difference is your money and it is trapped.
At getmyca, we specialise in recovering this stuck input tax credit for pharmaceutical companies across India. Export refunds, inverted duty structure claims, ITC refund for pharma manufacturers under Rule 89(5) we handle everything from calculation to bank credit. Full GST compliance, zero rejections.
Impact of GST on the Pharmaceutical Industry
GST was supposed to simplify taxes. For most businesses, it did. But for pharma manufacturers, it created a new silent problem inverted duty structure. You pay 18% GST on your raw materials and APIs. You collect only 5% GST on your finished medicines. That gap? It is your money and it is stuck.
After the GST 2.0 reforms of September 2025, this gap has become even wider. The new GST rules for pharmaceutical companies have moved finished drugs to 5% or Nil while APIs and packaging stay at 18%. GST for pharma companies now means one thing: ITC accumulation. And recovering it is no longer optional it is a cash flow decision.
GST Rates on Pharma Products Complete List 2026
Post September 2025 GST 2.0 reforms, medicine GST rate in India have changed significantly. Here is the complete GST rate structure for pharma products:
This rate gap APIs and packaging at 18% versus medicines at 5% is the reason pharmaceutical manufacturers accumulate crores of blocked ITC every year. This is the ITC refund pharma manufacturers are legally entitled to recover under Rule 89(5).
Why Pharma Manufacturers Face ITC Accumulation
What Is Inverted Duty Structure in Pharma?
Simple explanation: you pay 18% GST when you buy raw materials. You collect only 5% GST when you sell medicines. You always pay out more than you collect in. That extra amount the difference gets stuck in your Electronic Credit Ledger as blocked ITC. It is your money. The government is holding it. And you can legally claim it back.
ITC Accumulation Formula Rule 89(5)
ITC accumulation is the core problem for pharma manufacturers post GST 2.0. The government allows you to claim this stuck input tax credit back under Rule 89(5). The refund formula looks technical, but the idea is simple the more inverted your duty structure, the more you can recover.
Refund Formula Rule 89(5)
Net ITC x (Inverted Rated Turnover / Total Turnover) minus GST payable on those sales.
Break-even point: If your input share in total cost is above 27.8% (which is 5 divided by 18), your cash flow is being impacted by ITC accumulation. For most pharma manufacturers, input share is well above 27.8% meaning significant blocked input tax credit that can be legally recovered.
Real calculation example: API manufacturer with ₹90 raw material cost per unit at 18% GST = ₹16.20 ITC paid. Finished drug sold at ₹100 at 5% = ₹5 GST collected. Blocked ITC per unit = ₹11.20. On a turnover of ₹10 crore, that is ₹11.2 lakhs of blocked cash flow every year sitting idle in your GST ledger.
Check If Your Pharma Company Has Blocked GST Refund
Most pharmaceutical manufacturers are sitting on lakhs sometimes crores of unclaimed GST refund. API GST refund, bulk drug GST refund, inverted duty ITC refund getmyca assesses your exact eligibility for free. No commitment. No hidden charges.
Mon-Sat 9AM-7PM
Which Pharma Segments Are Most Affected?
Who Is Eligible for GST Refund in Pharmaceutical Industry?
Most pharma manufacturers assume GST refunds are only for exporters. That is wrong. If any of the following applies to your company, you qualify:
- Pharmaceutical exporters IGST refund on exports or ITC refund under LUT/Bond
- API manufacturers and bulk drug producers API GST refund under export or IDS category
- Manufacturers with inverted duty structure Rule 89(5) ITC refund claims
- Companies with excess GST payment refund from Electronic Cash Ledger via RFD-01
- Pharma units supplying to Special Economic Zones (SEZ) zero-rated supplies, full input tax credit refund
- Deemed export units EOU, EHTP, STP units under advance authorisation. These are treated on par with Special Economic Zones for GST refund purposes
- Companies that paid GST by mistake refund within 2 years of payment date
What Is 90% Provisional Refund in GST Now Available for All Pharma IDS Claimants
Most pharma companies do not know this exists and their CA never brings it up. Under Section 54(6) of CGST Act, 90% of your refund is credited to your bank account within just 7 days of filing. Not 60 days. Not 30 days. Seven days.
Big update: CGST Instruction 6/2025 dated October 1, 2025 extended the 90% provisional refund to inverted duty structure claimants not just exporters. This means if your pharma company is claiming a GST refund under Rule 89(5) for blocked input tax credit, you now qualify for 90% provisional payment within 7 days. This is the single biggest cash flow improvement for pharma manufacturers since GST was introduced and almost nobody knows about it.
Who Qualifies for 90% Provisional Refund
- Pharmaceutical exporters with clean GST compliance and filing history
- Pharma manufacturers claiming IDS refund under Rule 89(5) inverted duty structure
- Companies exporting under LUT without payment of IGST
- No pending pharma GST audit scrutiny, audit, or investigation by GST department
- No previous rejection of refund claims in the same category
Note
The remaining 10% is released after department verification, typically within 60 days. For pharma companies dealing with crores in blocked input tax credit, this single provision can transform your working capital position overnight.
Why Pharmaceutical GST Refund Claims Get Rejected And How getmyca Prevents It
Most pharma GST refund claims that fail are rejected for the same reasons. Not because the company was ineligible but because of avoidable errors. Here is exactly what goes wrong and how getmyca stops it from happening:
HSN Code Mismatch on Pharma Invoices
Pharma products have highly specific HSN codes 3003, 3004, 3006, 3808 and many more. One wrong HSN code on a purchase invoice, and your entire refund claim gets rejected automatically. No warning, no second chance. We cross-verify every HSN code in your invoices before touching the refund application.
GSTR-2B Reconciliation Failures
Your refund claim lives and dies by your GSTR-2B. If even one supplier filed their GSTR-1 late or made an error, that ITC vanishes from your GSTR-2B and your claim gets rejected. We reconcile every single entry, your books against portal data, ensure full GST compliance, and catch every supply chain vendor discrepancy before we file.
Wrong Rule 89 Calculation
The Rule 89(5) formula looks simple but excludes specific categories of ITC that most accountants miss. An incorrect calculation means your claim is either rejected or you recover less than you are owed. We run a detailed manual calculation and cross-verify before every single filing.
Missing Unjust Enrichment Certificate
Claims above ₹2 lakh require proof that you did not pass the GST cost on to your customer. No certificate, wrong format, missing CA signature instant rejection. We prepare this certificate as part of our standard process. You do not need to worry about it.
Claiming ITC on Input Services The Most Expensive Mistake
This is the mistake that costs pharma companies the most and almost nobody warns them about it. Under Rule 89(5), only ITC on physical input goods is eligible for an inverted duty structure refund. ITC on input services freight charges, CA fees, consultancy, legal fees, rent, insurance cannot be included in your IDS refund claim. If your accountant has included these in the calculation, your entire claim is either rejected or you face a demand notice later. We identify and exclude all ineligible ITC before filing so your claim is clean from day one.
Missed 2-Year Filing Deadline
This is the one mistake that cannot be fixed. GST refund claims must be filed within 2 years from the relevant date no extensions, no exceptions, no appeals. Once that window closes, the government keeps your money permanently. If you have unclaimed input tax credit from FY 2022-23, your deadline is already dangerously close.
How to Claim GST Refund for Pharmaceutical Manufacturers Step by Step
Free Eligibility Assessment
Analyse all GST returns and ledgers you get complete refund opportunity report with exact amounts.
GSTR-2B Reconciliation and Rule 89(5) Calculation
Verified refund amount with zero discrepancy.
Prepare Complete Documentation
RFD-01, annexures, certificates rejection-proof file ready for department.
File RFD-01 on GST Portal
Generate ARN number for tracking your claim. You can check your GST refund status anytime on the GST portal using this ARN.
Handle All Department Queries
Handle all department queries and deficiency memos you never speak to the department yourself.
PFMS Verification and Bank Credit
PFMS verification and follow-up until bank credit money in your account confirmed.
⚠ 2-Year Deadline Don’t Lose Your Refund
⚠ 90% Refund in 7 Days CGST Instruction 6/2025
⚡ Is Your Pharmaceutical Company Sitting on Unclaimed GST Refunds?
After GST 2.0, the inverted duty structure gap for pharma manufacturers is the widest it has ever been. APIs at 18%, medicines at 5% the blocked input tax credit is compounding every month. And the 2-year deadline does not wait.
getmyca has helped 500+ pharma manufacturers recover over ₹47 crore in blocked ITC across India recover their stuck GST credits. Our pharma specialists handle everything eligibility check, ITC calculation, RFD-01 filing, department queries, PFMS tracking until the money hits your bank account. Zero hidden charges. Complete transparency.
Free Consultation | No Commitment | Mon-Sat 9AM-7PM
Call or WhatsApp us today and we will tell you exactly how much your pharmaceutical company is owed.
FAQs GST Refund for Pharmaceutical Companies
Who is eligible for GST refund in pharma?+
Any pharmaceutical manufacturer with inverted duty structure (APIs at 18%, medicines at 5%), exporters, SEZ suppliers, ayurvedic medicine manufacturers, EOU/EHTP units, and companies with excess GST payments. After GST 2.0 reforms, nearly every drug pharmaceutical manufacturer qualifies.
What is 90% provisional refund in GST for pharma exporters?+
Under Section 54(6) of CGST Act and CGST Instruction 6/2025, eligible pharma exporters AND inverted duty structure claimants get 90% of their GST refund credited within 7 days of filing RFD-01. The remaining 10% follows after department verification within 60 days.
How to claim ITC refund for pharmaceutical manufacturers?+
File RFD-01 on the GST portal under inverted duty structure or export refund category. Documents needed: GSTR-3B, GSTR-2B reconciliation, supplier invoices, shipping bills (for exporters), and unjust enrichment certificate for claims above ₹2 lakh. Most self-filed claims get rejected professional filing is strongly recommended.
What is the time limit to claim GST refund for pharma companies?+
2 years from the relevant date. For inverted duty structure: from end of the financial year the claim arises. For exports: from date of export. No extensions, no appeals. Miss it and the money is gone permanently.
What does GST 18% apply to in pharma APIs or finished drugs?+
APIs, Key Starting Materials, excipients, solvents, and most packaging materials (glass, plastic, aluminium, metal) remain at 18% GST. Finished medicines are at 5% or Nil. That 18% vs 5% gap is the entire reason inverted duty structure refunds exist and why pharma manufacturers are owed crores in blocked input tax credit.
How much GST refund can a pharmaceutical company claim?+
It depends on your turnover, input mix, and export volume. A formulation company with ₹10 crore turnover typically recovers ₹8 to ₹12 lakhs annually. API exporters can recover significantly more. getmyca assesses your exact refund amount for free no commitment required.
What are the new GST rules for pharmaceutical companies in 2025?+
Under GST 2.0 (September 2025): 33 life-saving drugs = Nil GST, all medicines 12% reduced to 5%, medical devices 18% reduced to 5%, job work services 12% reduced to 5%. But APIs, packaging (glass, plastic, aluminium), and raw material inputs remain at 18%. This means inverted duty structure refunds are now available to almost every pharma manufacturer.
How to calculate GST on medicine and how much GST on medicine in India?+
Post September 2025: life-saving drugs = 0% GST, standard medicines = 5%, ayurvedic medicines = 12%, medical devices = 5%. To calculate: base price x GST rate. Medicine at ₹100 with 5% GST = ₹105 MRP. For manufacturers APIs and packaging at 18% against output at 5% professional input tax credit calculation matters before filing.
What is the impact of GST on pharmaceutical industry complete guide?+
This guide covers everything: GST 2.0 reforms, inverted duty structure, ITC accumulation formula, eligibility, rejection reasons, and full refund process. For a personalised analysis including exact refund amount and sector-wise breakdown contact getmyca for a free consultation.